Raymond James analyst doesn’t expect Arcturus’ COVID-19 vaccine to be authorized in the U.S.
Shares of Acturus Therapeutics Holdings Inc. were down 2.3% in trading on Wednesday after the company said two doses of its experimental COVID-19 vaccine had...